Related Experiment Video
Updated: Jul 7, 2026

Induction of Acute Ischemic Stroke in Mice Using the Distal Middle Artery Occlusion Technique
Published on: December 15, 2023
Neuroprotection for ischemic stroke: past, present and future.
1Department of Neurology (D4-5), University of Miami Miller School of Medicine, Miami, FL 33101, USA. mginsberg@med.miami.edu
Neuroprotection for ischemic stroke aims to prevent brain injury. While animal studies show promise, many clinical trials fail due to insufficient preclinical data and delayed treatment administration.
Area of Science:
- Neurology
- Pharmacology
- Translational Medicine
Background:
- Ischemic stroke neuroprotection research has rapidly expanded, with numerous experimental and clinical studies.
- Decades of research have identified multiple molecular and biochemical targets for neuroprotection.
- Animal models demonstrate the feasibility of achieving significant neuroprotection in ischemic brain injury.
Purpose of the Study:
- To review extensively evaluated neuroprotective agents and classes for ischemic stroke.
- To assess the strengths and weaknesses of preclinical evidence for neuroprotective agents.
- To analyze the results and shortcomings of clinical trials for neuroprotection.
Main Methods:
- Survey of extensively evaluated neuroprotective agents and classes.
- Evaluation of preclinical evidence (strengths and weaknesses).
- Analysis of clinical trial outcomes (results and shortcomings).
Main Results:
- Many agents advanced to clinical trials lacked robust preclinical support.
- A significant number of clinical trials failed, partly due to not administering therapy within the critical 4-6 hour therapeutic window.
- Promising strategies include therapeutic hypothermia, high-dose albumin, and hyperacute magnesium therapy.
Conclusions:
- Translational strategies and clinical trial design require improvement.
- Combination therapies hold potential for enhanced neuroprotection.
- Addressing issues in clinical trial funding and design is crucial for future success.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Stroke: Introduction and Types
Hemorrhagic Stroke l: Introduction
